FindTrial
Sign In

A Research of Prognostic Evaluation of Endovascular Therapy for Lower Extremity Artery Disease based on Machine Learning: a retrospective study based on medical records

A Research of Prognostic Evaluation of Endovascular Therapy for Lower Extremity Artery Disease based on Machine Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030068
Enrollment
Unknown
Registered
2020-02-22
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Arterial Ischemic Disease

Interventions

case series:N/A

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The chronic lower limb ischemic disease (Rutherford class 3-6), which was confirmed by imaging examination(CTA or DSA); 2) Be treated by endovascular treatment successfully for the first time and stent was sued to treat the lesion during th e surgery; 3)Complete baseline information and 2-year follow-up information.

Exclusion criteria

Exclusion criteria: 1) Inflammatory or autoimmune angiopathy; 2) Target limb has been treated with endovascular or open surgery; 3) The life-expectancy was less than 2 years with malignant tumor or serious adverse health events unrelated with vascular disease.

Design outcomes

Primary

MeasureTime frame
Major adverse limb event;—

Secondary

MeasureTime frame
Mortality;—

Countries

China

Contacts

Public ContactWeiguo Fu
fu.weiguo@zs-hospital.sh.cn+86 021-64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026